Video Shorts

1:08
Eli Lilly Cancels Bimagrumab for Type 2 Diabetes
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:54
Diabetes Dialogue: Celebrating 150 Episodes Preview!
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:24
Medical Ethics Unpacked: Why We Don’t Give Organs to the Sickest
8 months ago
by
Steve Levine, MD(+2 more)

0:49
Progress In Rare Kidney Disease: What Next?
8 months ago
by
Jai Radhakrishnan, MD

1:33
Enhancing Shared Decision-Making in Healthcare
8 months ago
by
Viet Le, DMSc, PA-C

1:07
Emerging Therapeutic Options for Alopecia Areata in Adolescents
8 months ago
by
Brittany Craiglow, MD

1:06
Medical Ethics Unpacked: Organ Transplants, No Cardiac Death Definition
8 months ago
by
Chelsie Derman

1:12
Type 2 Diabetes Patients Thrive With New Pump After 12 Months
8 months ago
by
Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES(+2 more)

1:05
Diabetes Automation: Freedom from Counting Every Bite
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+2 more)

1:36
How 780G Revolutionizes Sleep and Blood Sugar Control
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+2 more)

1:03
Spotlighting Data on Clearance of Actinic Keratosis Using Tirbanibulin
8 months ago
by
Neal Bhatia, MD

1:19
PAP Therapy Links to Improved Blood Pressure in Patients with Sleep Apnea
8 months ago
by
Chelsie Derman

1:23
Early Lung Gains Yield Better Long Term COPD Outcomes
8 months ago

1:11
Are Heart Failure Trials Ready for a Major Shift?
8 months ago
by
Stephen Greene, MD(+1 more)

1:47
The Evolving Landscape of CKM Trials: Recent Innovations and What’s Next
8 months ago
by
Brendon Neuen, MBBS, PhD(+2 more)

1:01
Hospitalizations vs Oral Diuretics as Heart Failure Trial Endpoints
8 months ago
by
Muthiah Vaduganathan, MD, MPH(+1 more)

1:49
Why Oral Diuretic Intensification Should Be a Heart Failure Trial Endpoint
8 months ago
by
Stephen Greene, MD(+1 more)

1:27
Tirzepatide’s Impact on Obstructive Sleep Apnea
8 months ago
by
Chelsie Derman

0:59
Semaglutide 7.2 Superior in Weight Loss
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:48
STEP-UP: A New Highest Dose of Semaglutide
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

1:06
ATTAIN-1: A New Oral GLP-1 for Obesity?
8 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)

0:50
Discussing Phase 2b Findings on Temtokibart for Atopic Dermatitis
8 months ago
by
Chi-ho Hong, MD, FRCPC

1:45
Navigating Evolutions in IgAN Therapeutics
8 months ago
by
Brendon Neuen, MBBS, PhD

2:09
Ritlecitinib 3-Year Data in Alopecia Areata Show Sustained Response, With Brett King, MD
9 months ago
by
Brett King, MD, PhD

0:53
MM120 Single Dose Rapidly Reduces Anxiety in GAD
9 months ago
by
Maurizio Fava, MD

1:01
Talking to Patients About Immunotherapy for Small Cell Lung Cancer
9 months ago
by
Jacob Sands, MD(+1 more)

1:24
The Importance of Teamwork in Hypertension Treatment
9 months ago
by
Pankaj Arora, MD

0:48
The Medical Sisterhood: Calendars, Clinics, and Chaos, With Amy Chen, MD
9 months ago
by
Mona Shahriari, MD, FAAD(+1 more)

0:51
Epinephrine Nasal Spray Shows Equal Efficacy to Injection in Real World Study
9 months ago
by
Chelsie Derman

1:26
Exciting New Therapy for Type 1 Diabetes Management
9 months ago
by
Klara Klein, MD, PhD
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
Machine Learning Model Predicts Type 2 Diabetes Risk Up To 10 Years Out
4
ACCESS: Aleniglipron Achieves Up To 11.3% Weight Loss in Phase 2b Obesity Trial
5
